Skip to main content

Progen Biotechnik Inks Deals for Assay Distribution, Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German firm Progen Biotechnik today announced an exclusive distribution agreement covering Germany with Asuragen to offer multiplexed assays based on Asuragen technology.

As a result of the deal, Progen can now offer assays incorporating Asuragen's Signature technology for the detection of mutations found in solid tumors, such as KRAS and BRAF, and fusion transcripts or mutations associated with specific leukemia types and subtypes, Progen said in a statement.

The Cologne-based company now can also offer two state-of-the-art PCR technologies developed by Asuragen for the molecular characterization of trinucleotide repeat in the 5' region of the fragile X mental retardation gene for routine screening, Progen added.

Financial and other terms of the deal were not disclosed.

Last week, Progen also announced a licensing deal with Mikrogen to co-develop, co-manufacture, and co-market multiplexed assays for the Luminex platform. The two companies will further "bundle their activities on equipment and application support" in connection with the Luminex technology, Progen said in a statement.

Under the deal, Mikrogen will concentrate on the routine laboratory market while Progen will concentrate on the research market and technical support and customized testing service markets.

Mikrogen, based in Neuried, Germany, develops diagnostics focused on bacterial, viral, and parasitic infections and autoimmune disorders, according to its website.

Terms of the deal were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.